Yantai Zhenghai Bio-Tech Co Ltd
SZSE:300653

Watchlist Manager
Yantai Zhenghai Bio-Tech Co Ltd Logo
Yantai Zhenghai Bio-Tech Co Ltd
SZSE:300653
Watchlist
Price: 21.87 CNY -2.84% Market Closed
Market Cap: 3.9B CNY
Have any thoughts about
Yantai Zhenghai Bio-Tech Co Ltd?
Write Note

Net Margin
Yantai Zhenghai Bio-Tech Co Ltd

43.8%
Current
44%
Average
-7.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
43.8%
=
Net Income
167.7m
/
Revenue
383.2m

Net Margin Across Competitors

Country CN
Market Cap 3.9B CNY
Net Margin
44%
Country FR
Market Cap 6T USD
Net Margin
-21 040%
Country US
Market Cap 310.3B USD
Net Margin
9%
Country US
Market Cap 141.6B USD
Net Margin
13%
Country US
Market Cap 115.3B USD
Net Margin
0%
Country US
Market Cap 102.4B USD
Net Margin
-5%
Country US
Market Cap 94.1B EUR
Net Margin
-392%
Country AU
Market Cap 134.4B AUD
Net Margin
18%
Country US
Market Cap 77.3B USD
Net Margin
34%
Country US
Market Cap 39.3B EUR
Net Margin
-33%
Country NL
Market Cap 35.8B EUR
Net Margin
-14%
No Stocks Found

Yantai Zhenghai Bio-Tech Co Ltd
Glance View

Market Cap
3.9B CNY
Industry
Biotechnology

Yantai Zhenghai Bio-Tech Co., Ltd. engages in the research & development, production, and sale of regenerative medicine related products such as soft tissue, and hard tissue repair materials. The company is headquartered in Yantai, Shandong and currently employs 378 full-time employees. The company went IPO on 2017-05-16. The firm has two types of products which are soft tissue repair materials and hard tissue repair materials. The soft tissue repair materials include oral repair membranes, biofilms and skin repair membranes. The hard tissue repair materials include bone repair materials.

Intrinsic Value
26.96 CNY
Undervaluation 19%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
43.8%
=
Net Income
167.7m
/
Revenue
383.2m
What is the Net Margin of Yantai Zhenghai Bio-Tech Co Ltd?

Based on Yantai Zhenghai Bio-Tech Co Ltd's most recent financial statements, the company has Net Margin of 43.8%.